Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
Goiter01:27

Goiter

Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Serum adipocytokine levels in patients with renal cell carcinoma.

Endokrynologia Polska·2026
Same author

Lipidogram profiles in patients with Graves' and Basedow's disease with and without orbitopathy.

Endokrynologia Polska·2026
Same author

Is vitamin D deficiency a risk factor for obesity-related morbidity, prediabetes, and type 2 diabetes - a literature review and proposals from the experts of the Polish Society of Endocrinology.

Endokrynologia Polska·2025
Same author

Sarcoidosis unmasked by Cushing's syndrome: successful surgical resolution.

Archives of medical science : AMS·2025
Same author

The position of monoclonal antibodies and small molecules in the treatment of thyroid orbitopathy.

Endokrynologia Polska·2025
Same author

Adrenal tumours and subclinical adrenal hyperfunction.

Endokrynologia Polska·2025

Related Experiment Video

Updated: Jul 8, 2026

In vivo Characterization of Endocrine Disrupting Chemical Effects via Thyroid Hormone Action Indicator Mouse
04:14

In vivo Characterization of Endocrine Disrupting Chemical Effects via Thyroid Hormone Action Indicator Mouse

Published on: October 6, 2023

[Subclinical hyperthyroidism].

Robert Krysiak1, Bogdan Marek, Bogusław Okopień

  • 1Klinika Chorób Wewnetrznych i Farmakologii Klinicznej Katedry Farmakologii, Slaski Uniwersytet Medyczny, Katowice. r.krysiak@poczta.onet.pl

Endokrynologia Polska
|January 22, 2008
PubMed
Summary

Subclinical hyperthyroidism, a condition with low thyroid stimulating hormone (TSH), is common and may lead to heart issues, bone loss, and cognitive decline. Management remains debated.

Area of Science:

  • Endocrinology
  • Internal Medicine

Context:

  • Subclinical hyperthyroidism is defined by suppressed serum TSH with normal thyroxine and tri-iodothyronine levels.
  • Prevalence ranges from 0.6% to 16% in the general population.
  • This condition carries risks for cardiovascular complications, osteoporosis, and dementia.

Purpose:

  • To provide a comprehensive overview of subclinical hyperthyroidism.
  • To discuss current knowledge on prevalence, pathogenesis, clinical presentation, diagnosis, complications, and treatment.
  • To highlight the ongoing controversy regarding management indications.

Summary:

  • Subclinical hyperthyroidism involves reduced TSH with normal thyroid hormone levels.
  • It is associated with increased risks of atrial fibrillation, osteoporosis, and dementia.

More Related Videos

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
04:39

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Published on: March 17, 2023

Related Experiment Videos

Last Updated: Jul 8, 2026

In vivo Characterization of Endocrine Disrupting Chemical Effects via Thyroid Hormone Action Indicator Mouse
04:14

In vivo Characterization of Endocrine Disrupting Chemical Effects via Thyroid Hormone Action Indicator Mouse

Published on: October 6, 2023

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
04:39

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Published on: March 17, 2023

  • Treatment decisions for subclinical hyperthyroidism are not standardized.

    • Impact:

    • Informs clinicians about the risks and diagnostic criteria of subclinical hyperthyroidism.
    • Highlights the need for further research into optimal management strategies.
    • Aims to improve patient outcomes by clarifying prognosis and potential complications.